AM679
AM679 is a potent, selective 5-lipoxygenase-activating protein (FLAP) inhibitor with an IC50 of 2 nM in a human FLAP membrane binding assay. AM679 markedly reduces the respiratory syncytial virus-driven ocular pathology as well as the synthesis of cysteinyl leukotrienes (CysLTs) in the eye[1].
Product Specifications
CAS Number
1206880-66-1
UNSPSC
12352005
Target
FLAP
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/AM679.html
Purity
99.72
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(C)N1C2=CC=CC=C2C[C@H]1COC3=CC=C(N(CC4=CC=C(C5=NC=C(OC)C=N5)C=C4)C(CC(C)(C(O)=O)C)=C6SC(C)(C)C)C6=C3
Molecular Formula
C40H44N4O5S
Molecular Weight
692.87
References & Citations
[1]Stock, N, et al. 5-Lipoxygenase-activating protein inhibitors. Part 2: 3-{5- ((S) -1-Acetyl-2,3-dihydro-1H-indol-2-ylmethoxy) -3-tert-butylsulfanyl-1-[4- (5-methoxy-pyrimidin-2-yl) -benzyl]-1H-indol-2-yl}-2,2-dimethyl-propionic acid (AM679) -A potent FLAP inhibitor. Bioorganic & Medicinal Chemistry Letters (2010), 20 (1), 213-217.|[2]Musiyenko, A, et al. A novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eye. Clinical and Vaccine Immunology (2009), 16 (11), 1654-1659.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
31319111 3x 1.0 µg
MYP11 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 247432-HRP 100 µL
IFNA2 (Interferon, alpha 2, IFNA, INFA2, MGC125764, MGC125765) (HRP)
Sign In for Pricing
View Details